loading

Cellectar Biosciences Inc Borsa (CLRB) Ultime notizie

pulisher
01:49 AM

How analysts rate Cellectar Biosciences Inc. stock todayWeekly Trend Recap & Consistent Profit Alerts - newser.com

01:49 AM
pulisher
01:49 AM

Using Python tools to backtest Cellectar Biosciences Inc. strategiesJuly 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com

01:49 AM
pulisher
Oct 12, 2025

Predicting Cellectar Biosciences Inc. trend using moving averagesSell Signal & Daily Growth Stock Investment Tips - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Is Cellectar Biosciences Inc. meeting your algorithmic filter criteriaEarnings Overview Report & Weekly Watchlist of Top Performers - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

What drives Cellectar Biosciences Inc stock priceLow Risk Investment Ideas & Free Record-Breaking Gains - earlytimes.in

Oct 11, 2025
pulisher
Oct 11, 2025

Cellectar Biosciences Raises $5.8M Through Warrant Exercise - MSN

Oct 11, 2025
pulisher
Oct 11, 2025

Cellectar Biosciences raises $5.8 million through warrant exercise and new inducement warrants - Investing.com Canada

Oct 11, 2025
pulisher
Oct 10, 2025

Will Cellectar Biosciences Inc. price bounce be sustainable2025 Top Decliners & Daily Profit Focused Screening - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What technical models suggest about Cellectar Biosciences Inc.’s comebackEntry Point & High Conviction Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Understanding Cellectar Biosciences Inc.’s price movementWeekly Investment Summary & AI Forecasted Entry and Exit Points - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Cellectar Biosciences Inc. stock prediction for this weekMarket Rally & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Custom watchlist performance reports with Cellectar Biosciences Inc.CPI Data & Long-Term Growth Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Analyzing net buyer seller activity in Cellectar Biosciences Inc.Quarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Cellectar Biosciences Stock Drops 17% On $5.8M Fundraise: Retail Awaits An ‘Impending’ Rally - MSN

Oct 08, 2025
pulisher
Oct 07, 2025

Cellectar Biosciences (CLRB) Secures $5.8 Million Through Warran - GuruFocus

Oct 07, 2025
pulisher
Oct 07, 2025

Cellectar Biosciences raises $5.8 million through warrant exercise - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

Cellectar Biosciences enters agreements to raise $5.8M - TipRanks

Oct 07, 2025
pulisher
Oct 07, 2025

Cellectar Biosciences raises $5.8 million through warrant exercise By Investing.com - Investing.com Australia

Oct 07, 2025
pulisher
Oct 07, 2025

Cellectar Biosciences, Inc. enters into agreements to raise $5.8 million - MarketScreener

Oct 07, 2025
pulisher
Oct 07, 2025

Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million - GlobeNewswire

Oct 07, 2025
pulisher
Oct 07, 2025

$5.8M Raised: Cellectar Biosciences Secures Funding via Warrant Exercises to Advance CLR 121125 - Stock Titan

Oct 07, 2025
pulisher
Oct 06, 2025

Cellectar’s cancer drug advances toward European approval By Investing.com - Investing.com Nigeria

Oct 06, 2025
pulisher
Oct 06, 2025

Cellectar Biosciences Announces European Medicines Agency - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Cellectar Biosciences (CLRB) Receives Positive Feedback for EU M - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

What margin trends mean for Cellectar Biosciences Inc. stockEarnings Recap Summary & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Cellectar’s cancer drug advances toward European approval - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Cellectar Biosciences Stock Rises Over EMA's Advise On CMA Filing For Iopofosine I 131 - Nasdaq

Oct 06, 2025
pulisher
Oct 06, 2025

Cellectar Biosciences (CLRB) Moves Toward European Market with Potential Cancer Treatment - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

Cellectar wins EMA nod to seek conditional approval for iopofosine in rare blood cancer - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Cellectar Biosciences Plans Conditional Marketing Authorization Submission for Iopofosine I 131 as Treatment for Refractory Waldenstrom Macroglobulinemia in Europe by Early 2026 - Quiver Quantitative

Oct 06, 2025
pulisher
Oct 06, 2025

Cellectar Biosciences Announces European Medicines Agency (EMA) Confirms Eligibility to File for Conditional Marketing Authorization (CMA) for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) Waldenstrom Macroglobulinemia (WM) - The Manila Times

Oct 06, 2025
pulisher
Oct 06, 2025

Cellectar Biosciences Announces Iopofosine I 131 as A Treatment for Refractory (Post-Btki) Waldenstrom Macroglobulinemia (Wm) - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Is Cellectar Biosciences Inc. stock a safe haven assetSell Signal & Long-Term Safe Investment Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How Cellectar Biosciences Inc. stock benefits from tech adoption2025 Market Overview & Real-Time Volume Analysis - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How to forecast Cellectar Biosciences Inc. trends using time series2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can Cellectar Biosciences Inc. (NV4) stock hold up in economic slowdownTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 05, 2025
pulisher
Oct 01, 2025

What drives Cellectar Biosciences Inc NV4 stock priceIndustrial Stocks Review & Predict Price Movements With AI Precision - earlytimes.in

Oct 01, 2025
pulisher
Sep 30, 2025

Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer - GlobeNewswire

Sep 30, 2025
pulisher
Sep 30, 2025

8.6-Month Survival: Cellectar's Novel Radiotherapy Shows Promise in Incurable Pediatric Brain Cancer Trial - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

Can you recover from losses in Cellectar Biosciences Inc.Portfolio Gains Report & Safe Swing Trade Setups - newser.com

Sep 30, 2025
$84.54
price up icon 1.04%
$22.76
price up icon 6.16%
$32.48
price up icon 2.23%
$102.23
price up icon 0.32%
$165.94
price up icon 2.27%
biotechnology ONC
$330.74
price up icon 3.34%
Capitalizzazione:     |  Volume (24 ore):